Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Virus-drug resistance: thymidine kinase-deficient (TK-) mutants of herpes simplex virus. Therapeutic approaches. — De Clercq Erik (1987) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Virus-drug resistance: thymidine kinase-deficient (TK-) mutants of herpes simplex virus. Therapeutic approaches.
Shared by
De Clercq Erik
KU Leuven
Virus-drug resistance: thymidine kinase-deficient (TK-) mutants of herpes simplex virus. Therapeutic approaches.
Article
1987
it
Related publications
Article
1987
Efficacy of (S)-HPMPA against thymidine kinase-deficient herpes simplex virus-keratitis.
P. C. Maudgal
,
De Clercq Erik
,
Philippe Huyghe
Article
1987
Potent activity of 5-fluoro-2'-deoxyuridine and related compounds against thymidine kinase-deficient (TK-) herpes simplex virus: targeted at thymidylate synthase.
De Clercq Erik
,
J. Béres
,
Authors
De Clercq Erik
KU Leuven
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Wesley G. Bentrude
Article
1980
The 5'-monophosphates of 5-propyl- and 5-ethyl-2'-deoxyuridine do not inhibit the replication of deoxythymidine kinase deficient (TK-) mutants of herpes simplex virus
De Clercq Erik
,
Tadeusz Kulikowski
,
David Shugar
Article
2005
Characterization of Herpes Simplex Virus Type 1 Thymidine Kinase Mutants Selected under a Single Round of High-Dose Brivudin
Graciela Andreï
,
Jan Balzarini
,
Pierre Fiten
,
De Clercq Erik
,
Ghislain Opdenakker
,
Robert Snoeck
Article
1999
Characterization of Multiple Nuclear Localization Signals in Herpes Simplex Virus Type 1 Thymidine Kinase
Bart Degrève
,
Robert Esnouf
,
De Clercq Erik
,
Jan Balzarini
Discussion(0)
No comments yet. Be the first to comment.